IR Calendar

Upcoming Events

There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases.

Past Events

Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

CytoDyn Presentations at
CROI 2017
Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

LD Micro Main Event

Luxe Sunset Hotel, Los Angeles, CA

CytoDyn Investment Community Presentation

The presentation by Dr. Nader Pourhassan, President and CEO, addressed previous public disclosures regarding CytoDyn's Phase 3 combination therapy trial protocol modifications and timelines for other initiatives.

CytoDyn Investment Community Call to Discuss Phase 3 Trial Protocol Modifications and Other Updates
Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).
Rodman & Renshaw 18th Annual Global Investment Conference

Lotte New York Palace Hotel, New York City

2016 Annual Meeting of Stockholders

Hilton Vancouver Washington

Click here to view proxy material for Annual Meeting.

CytoDyn Investment Community Conference Call

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

CytoDyn Investment Community Conference Call
ASM Microbe Conference

PRO 140 SC Monotherapy provides long-term full virologic suppression in HIV patients
Presented by: Paul J. Maddon, MD, Ph.D.
Click here for presentation

LD Micro Invitational Conference

Luxe Sunset Bel Air Hotel, Los Angeles, CA

Click the webcast link below for an audio and video replay of CytoDyn's presentation.

Interview with the CEO

Stock News Now Interview of Nader Pourhassan, President & CEO of CytoDyn at LD Micro Invitational Conference

Click here for interview

CytoDyn Investment Community Conference Call
CytoDyn Investment Community Conference Call
CytoDyn Investment Community Conference Call
CytoDyn Investment Community Conference Call
Investment Community Update
CytoDyn Investment Community Call to Discuss Today's Submission of Phase 3 Protocol to FDA and Upcoming Plans
CytoDyn Investment Community Call to Discuss Interim Results from its Treatment Substitution Study in Patients with HIV
2014 Annual Shareholder Meeting
CytoDyn Investment Community Conference Call
Investor Update Conference Call
Investor Update Conference Call
31st Annual J.P. Morgan Healthcare Conference